(Q39606679)

13 September 2017

The constitutive activity of the ALK mutated at positions F1174 or R1275 impairs receptor trafficking (English)

1 reference

Isabelle Janoueix-Lerosey

13 September 2017

object named as

I Janoueix-Lerosey

10

0 references

Olivier Delattre

9

object named as

O Delattre

1 reference

13 September 2017

P Mazot

1

1 reference

13 September 2017

A Cazes

2

1 reference

13 September 2017

M C Boutterin

3

1 reference

13 September 2017

A Figueiredo

4

1 reference

13 September 2017

V Raynal

5

1 reference

13 September 2017

V Combaret

6

1 reference

13 September 2017

B Hallberg

7

1 reference

13 September 2017

R H Palmer

8

1 reference

13 September 2017

M Vigny

11

1 reference

13 September 2017

language of work or name

English

0 references

publication date

17 January 2011

1 reference

13 September 2017

1 reference

13 September 2017

30

1 reference

13 September 2017

2017-2025

1 reference

13 September 2017

17

1 reference

https://scigraph.springernature.com/pub.10.1038/onc.2010.595

13 September 2017

0 references

cites work

Ubiquitin conjugase UBCH8 targets active FMS-like tyrosine kinase 3 for proteasomal degradation

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.595

Oncogenic mutations of ALK kinase in neuroblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.595

Mislocalized activation of oncogenic RTKs switches downstream signaling outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.595

Identification of NVP-TAE684, a potent, selective, and efficacious inhibitor of NPM-ALK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.595

Activating mutations in ALK provide a therapeutic target in neuroblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.595

Roles of N-linked glycans in the endoplasmic reticulum

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.595

SHP1 tyrosine phosphatase negatively regulates NPM-ALK tyrosine kinase signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.595

Molecular characterization of ALK, a receptor tyrosine kinase expressed specifically in the nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.595

Somatic and germline activating mutations of the ALK kinase receptor in neuroblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.595

Molecular pathogenesis of peripheral neuroblastic tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.595

Assembly of asparagine-linked oligosaccharides

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.595

Expression of the ALK tyrosine kinase gene in neuroblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.595

The kinase activity of fibroblast growth factor receptor 3 with activation loop mutations affects receptor trafficking and signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.595

Identification and characterization of DAlk: a novel Drosophila melanogaster RTK which drives ERK activation in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.595

Anti-epidermal growth factor receptor monoclonal antibodies in cancer therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.595

In contrast to agonist monoclonal antibodies, both C-terminal truncated form and full length form of Pleiotrophin failed to activate vertebrate ALK (anaplastic lymphoma kinase)?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.595

Activation of anaplastic lymphoma kinase is responsible for hyperphosphorylation of ShcC in neuroblastoma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.595

Activation and inhibition of anaplastic lymphoma kinase receptor tyrosine kinase by monoclonal antibodies and absence of agonist activity of pleiotrophin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.595

ALK, the chromosome 2 gene locus altered by the t(2;5) in non-Hodgkin's lymphoma, encodes a novel neural receptor tyrosine kinase that is highly related to leukocyte tyrosine kinase (LTK)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.595

Identification of ALK as a major familial neuroblastoma predisposition gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.595

Inhibition of ALK signaling for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.595

ALK receptor tyrosine kinase promotes cell growth and neurite outgrowth

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.595

Anaplastic lymphoma kinase is a dependence receptor whose proapoptotic functions are activated by caspase cleavage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.595

Biological role of anaplastic lymphoma kinase in neuroblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.595

Anaplastic lymphoma kinase: signalling in development and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.595

Anaplastic lymphoma kinase is activated through the pleiotrophin/receptor protein-tyrosine phosphatase beta/zeta signaling pathway: an alternative mechanism of receptor tyrosine kinase activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.595

C. elegans anaplastic lymphoma kinase ortholog SCD-2 controls dauer formation by modulating TGF-beta signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.595

Tyrosine phosphorylation regulates maturation of receptor tyrosine kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.595

Characterization of the expression of the ALK receptor tyrosine kinase in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.595

Anaplastic lymphoma kinase: role in cancer pathogenesis and small-molecule inhibitor development for therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.595

The ligand Jelly Belly (Jeb) activates the Drosophila Alk RTK to drive PC12 cell differentiation, but is unable to activate the mouse ALK RTK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.595

High incidence of DNA mutations and gene amplifications of theALKgene in advanced sporadic neuroblastoma tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.595

https://api.fatcat.wiki/v0/release/ksoq3442rjek5geygziidayqpe

31 March 2020

Identifiers

1 reference

mapped directly with Wikidata item

30 July 2022

based on heuristic

Dimensions Publication ID

1049582141

0 references

Fatcat ID

release_ksoq3442rjek5geygziidayqpe

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ksoq3442rjek5geygziidayqpe

mapped directly with Wikidata item

30 July 2022

based on heuristic

1 reference

https://api.fatcat.wiki/v0/release/ksoq3442rjek5geygziidayqpe